Diagnos Laboratorium Utama Tbk. vs Widiant Jaya Krenindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Widiant Jaya Krenindo Tbk. trades at Rp26 (market cap 41.6B, 3.18M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 7.5× Widiant Jaya Krenindo Tbk.'s market cap, and Widiant Jaya Krenindo Tbk. is more actively traded (3.18M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | WIDI | |
|---|---|---|
Market Cap | 310.75B | 41.6B |
Volume | 963.6K | 3.18M |
Lot | 9.64K | 31.8K |
Turnover | 217.67M | 80.66M |
Average Price | 225.89 | 25.37 |
Value | 217.67M | 80.66M |
Indicative Equilibrium Price | 226 | 26 |
Indicative Equilibrium Volume | 1K | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Widiant Jaya Krenindo Tbk (the Company) was established based on Notarial Deed No. 2 of Ruping Lolo Alias Vince, S.H., Notary in Karawang, dated August 13, 2016. The Company begin their operation activities in 2016.
Read more on WIDI →